Genomic Repurposing Of Drugs To Treat Brain Diseases

Hardcover | June 1, 2017

byMatthew ReillyEditorAjay Pillai

not yet rated|write a review
Genomic Repurposing of Drugs to Treat Brain Diseases, the latest volume in the International Review of Neurobiology series, is a comprehensive overview of the state-of-the-art research into genomic repurposing of drugs to treat brain diseases. It reviews current knowledge and understanding and provides a starting point for researchers and practitioners entering the field. Contains the expertise of contributors who are leaders in the field of genomic repurposing of drugs to treat brain disorders Reviews current knowledge and understanding, and provides a starting point for researchers and practitioners entering the field Includes information on the latest research and advancements on the topic

Pricing and Purchase Info

$286.30 online
$326.19 list price (save 12%)
Pre-order online
Ships free on orders over $25

From the Publisher

Genomic Repurposing of Drugs to Treat Brain Diseases, the latest volume in the International Review of Neurobiology series, is a comprehensive overview of the state-of-the-art research into genomic repurposing of drugs to treat brain diseases. It reviews current knowledge and understanding and provides a starting point for researchers ...

Format:HardcoverDimensions:322 pages, 9.41 × 7.24 × 0.98 inPublished:June 1, 2017Publisher:Academic PressLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:0128039566

ISBN - 13:9780128039564

Look for similar items by category:

Customer Reviews of Genomic Repurposing Of Drugs To Treat Brain Diseases

Reviews

Extra Content

Table of Contents

1. Identify functional modulators of ionotropic neurotransmitter receptors in brain

Susumu Tomita

2. Physical Exam of Human Neurons to Identify Functions of the Druggable Genome

Steven Finkbeiner

3. Applications of high-throughput genomics screens for drug discovery for AUDs

Pietro Sanna

4. Neuron and Glial Cellular Signatures from Normal and Diseased iPS Cells

Leslie Thompson